Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. | Brief Bioinform | 2021 | 34009288 | PubTator, text mining | PubMed |
| Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins. | Chem Heterocycl Compd (N Y) | 2021 | 34007082 | PubTator, text mining | PubMed |
| Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis. | Infect Genet Evol | 2021 | 34004362 | PubTator, text mining | PubMed |
| Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review. | Trends Analyt Chem | 2021 | 33994605 | PubTator, text mining | PubMed |
| A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19. | PeerJ | 2021 | 33981493 | PubTator, text mining | PubMed |
| Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. | Clin Microbiol Rev | 2021 | 33980688 | PubTator, text mining | PubMed |
| SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. | Nat Commun | 2021 | 33976134 | PubTator, text mining | PubMed |
| Advances in the Development of Antiviral Compounds for Rotavirus Infections. | mBio | 2021 | 33975930 | PubTator, text mining | PubMed |
| Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. | Cell Rep | 2021 | 33974846 | PubTator, text mining | PubMed |
| Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development. | J Pharmacol Exp Ther | 2021 | 33972366 | PubTator, text mining | PubMed |
| Interplay between SARS-CoV-2 and human long non-coding RNAs. | J Cell Mol Med | 2021 | 33969601 | PubTator, text mining | PubMed |
| Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection. | Virusdisease | 2021 | 33969150 | PubTator, text mining | PubMed |
| Rotavirus in Calves and Its Zoonotic Importance. | Vet Med Int | 2021 | 33968359 | PubTator, text mining | PubMed |
| Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. | Front Microbiol | 2021 | 33967984 | PubTator, text mining | PubMed |
| SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. | Front Pharmacol | 2021 | 33967772 | PubTator, text mining | PubMed |
| SARS-CoV-2 promote autophagy to suppress type I interferon response. | Signal Transduct Target Ther | 2021 | 33966045 | PubTator, text mining | PubMed |
| A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19. | J Biomed Inform | 2021 | 33965637 | PubTator, text mining | PubMed |
| Therapeutic approaches for SARS-CoV-2 infection. | Methods | 2021 | 33962011 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Rotavirus gastroenteritis in Pakistan, 2018: updated disease burden. | BMC Infect Dis | 2021 | 33957883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=84